ESR2 and benign prostatic hyperplasia: Moreover, recent evidence indicates that estrogen also contributes to the pathogenesis of BPH, with distinct roles for estrogen receptor subtypes ERα and ERβ in prostate cell growth, involving mechanisms like cell death, aromatase activity, and regulation via PGE2 [35].